GMP production of active pharmaceutical ingredients

BIOMEVA's facility is dedicated to the large-scale manufacturing of APIs expressed in microbial systems. Recombinant material on a clinical and commercial scale can be produced in batches up to 1000 L working volume.

Production and purification systems include:

Fermenters with working volumes of 10 L, 100 L and 1000 L
Continuous centrifugation
High-pressure homogenization
Protein micro-filtration and ultra-filtration
Sterile filtration
Column chromatography
Bulk drug substance filling